Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Pharmaceuticals Major
|MRK||Merck & Co., Inc.||0.64%||81.67||0.7%||$1580.82m|
|JNJ||Johnson & Johnson||0.24%||164.11||0.7%||$1029.23m|
|BMY||Bristol-Myers Squibb Co.||0.33%||57.79||1.0%||$632.94m|
|LLY||Eli Lilly & Co.||0.59%||245.19||1.1%||$607.90m|
|AVIR||Atea Pharmaceuticals, Inc.||-0.08%||12.72||0.3%||$130.94m|
|NVO||Novo Nordisk A/S||0.13%||106.15||0.1%||$90.14m|
|OGN||Organon & Co.||3.45%||36.89||0.0%||$53.15m|
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.